US-based Vertex Pharmaceuticals Incorporated has announced that the Saudi Food and Drug Authority (SFDA) has g...
The Centre for Chinese Herbal Medicine Drug Development of Hong Kong Baptist University (HKBU) has develo...
Kite Pharma, a Gilead Company, is a global biopharmaceutical company specializing in cancer cell therapy As the global c...
GYSS 2024 is celebrating the values of science promoting collaboration and teamwork in Singapore from 8 to 12 January 20...
Denmark headquartered Novo Nordisk Foundation is committing up to $25 million to support the early-stage devel...
China-based startup SanReno Therapeutics, a clinical-stage company specializing in the discovery, development...
A research team from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of S...
Changchun GeneScience Pharmaceutical (GenSci), a subsidiary of Changchun High-Tech Industries (Group), recently held a g...
Singapore-based biotech startup ImmunoScape has announced a partnership with the Experimental Drug Development Centre (E...
Austrianova, a member of the SGAustria group of companies, and a leading provider of cell encapsulated products as well ...
Scientists led by Duke-NUS Medical School in Singapore and the University of California, Los Angeles, (UCLA) in the Un...
An international team of researchers, led by Pfizer in collaboration with Monash University and the Australian-based Can...
Assistant Professor Cheow Lih Feng from the National University of Singapore's (NUS) Institute for H...
Medlab Middle East, the region's largest medical laboratory exhibition, will bring together leading researchers in NextG...
Scientists from Duke-NUS Medical School (Duke-NUS) in Singapore and their collaborators have come up with new methods to...
The multi-target research and development partnership will focus on severe skin diseases • &nbs...
In a world-first, researchers at the Royal Adelaide Hospital (RAH) and the University of Adelaide in Australia are seeki...
The third edition of the "Asia Pacific Forum on Precision Cancer Treatment" concluded today with a dynamic exchange of i...
